N-Nitroso Tadalafil
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Tadalafil is used to treat men who have erectile dysfunction (also called sexual impotence). Tadalafil belongs to a group of medicines called phosphodiesterase 5 (PDE5) inhibitors. These medicines prevent an enzyme called phosphodiesterase type-5 from working too quickly.Tadalafil Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Tadalafil or Tadalafil Nitroso Impurity 1 CAS NO:NA also known as N-Nitroso Tadalafil Impurity Chemically represented as (6R,12aR)-6-(Benzo[d][1,3]dioxol-5-yl)-2-methyl-7-nitroso-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione . Synchemia is the leading manufacturing and exporter of Tadalafil Nitroso Impurity 1 . We supply Tadalafil Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143668 |
| CAS No | NA |
| Mol.F. | C19H20N4O2 |
| Mol.Wt. | 336.4 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143669 |
| CAS No | NA |
| Mol.F. | C28H36N4O6 |
| Mol.Wt. | 524.62 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143670 |
| CAS No | NA |
| Mol.F. | C29H37N3O7 |
| Mol.Wt. | 539.63 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143671 |
| CAS No | NA |
| Mol.F. | C11H21N3O5 |
| Mol.Wt. | 275.30 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143672 |
| CAS No | NA |
| Mol.F. | C25H30N4O7 |
| Mol.Wt. | 498.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143673 |
| CAS No | NA |
| Mol.F. | C20H22N4O5 |
| Mol.Wt. | 398.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143674 |
| CAS No | NA |
| Mol.F. | C20H21N5O6 |
| Mol.Wt. | 427.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143675 |
| CAS No | NA |
| Mol.F. | C14H10D8N6O3 |
| Mol.Wt. | 326.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143676 |
| CAS No | NA |
| Mol.F. | C9H7D8N3O3 |
| Mol.Wt. | 221.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143677 |
| CAS No | 20002-25-9 |
| Mol.F. | C11H16N2O |
| Mol.Wt. | 192.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143678 |
| CAS No | NA |
| Mol.F. | C13H23N5O4S |
| Mol.Wt. | 345.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143679 |
| CAS No | NA |
| Mol.F. | C13H23N5O4S |
| Mol.Wt. | 345.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143680 |
| CAS No | NA |
| Mol.F. | C19H30N8O5S2 |
| Mol.Wt. | 514.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143681 |
| CAS No | NA |
| Mol.F. | C17H25N5O7S |
| Mol.Wt. | 443.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143682 |
| CAS No | NA |
| Mol.F. | C17H8D8N4OS |
| Mol.Wt. | 332.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143683 |
| CAS No | NA |
| Mol.F. | C21H27N3O6 |
| Mol.Wt. | 417.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |